Structural Insights into Bromodomain-Containing Complexes from Trypanosoma cruzi Revealed by Proximity Labeling and Stoichiometric Space Exploration

This study combines proximity labeling and novel stoichiometric structure prediction to map the composition and architecture of *Trypanosoma cruzi* bromodomain-containing CRKT and NuA4 complexes, providing a structural foundation for rational drug design against Chagas disease.

The Gist

The Big Picture: A Mystery in a Tiny Invader

Imagine Trypanosoma cruzi as a microscopic, shape-shifting burglar that causes a disease called Chagas. For decades, we've tried to catch this burglar with only two old, rusty keys (drugs) that don't work very well and often make the homeowner (the patient) sick.

Inside this burglar's cell, there is a sophisticated security system made of proteins. One specific type of protein, called a Bromodomain Factor (BDF), acts like a "magnetic hook." These hooks are designed to grab onto other proteins that have been marked with a special "sticky note" (acetylation). When these hooks grab their targets, they form massive teams (complexes) that control how the burglar's genes are read and used.

The scientists in this paper wanted to answer two big questions:

1. Who is on these teams? (Which proteins are holding hands?)
2. What do these teams look like? (How are they built?)

If we can understand the blueprint of these teams, we might be able to design a new, super-specific key that jams their gears, stopping the burglar without hurting the homeowner.

---

The Detective Work: The "TurboID" Glue

To figure out who is working with whom, the scientists used a clever trick called TurboID.

Imagine you are at a crowded party and you want to know who your friend is talking to. You could try to listen to every conversation, but that's messy. Instead, imagine your friend has a special super-glue gun (TurboID) attached to their back.

1. The Setup: The scientists attached this "glue gun" to different BDF proteins inside the parasite.
2. The Action: When the glue gun is turned on, it sprays a sticky "biotin" tag onto anyone standing within a few feet of the bait protein.
3. The Catch: Later, they used a giant magnet (streptavidin beads) to pull out everything that got tagged.
4. The Result: By looking at who got stuck to the magnet, they could map out the "social network" of the parasite. They found two main groups of friends hanging out together:
   • The CRKT Team: A group focused on reading genes.
   • The NuA4 Team: A group focused on modifying DNA.

The Surprise: Some Friends Live in Different Houses

Usually, these "magnetic hooks" (BDFs) live in the nucleus (the control center) of the cell. But in this specific burglar (T. cruzi), the scientists found something weird:

• BDF1 and BDF3 were hanging out in the cytoplasm (the outer living room of the cell), not the control center.
• This is like finding the security guards of a bank actually hanging out in the parking lot. It suggests they might be doing a different job, perhaps preparing the "sticky notes" before the DNA even gets into the control center.

The 3D Puzzle: Building the Blueprint

Knowing who is friends isn't enough; we need to know how they fit together in 3D space. The scientists used a super-smart AI (AlphaFold3) to predict what these protein teams look like. Think of this as using a computer to solve a 3D jigsaw puzzle where the pieces are invisible.

They discovered two unique structures:

1. The NuA4 Team: The "Piccolo" Orchestra

In humans and yeast, the NuA4 team is a massive, 13-piece orchestra. But in this parasite, they found a smaller, streamlined version called "Piccolo-NuA4."

• The Analogy: Imagine a full symphony orchestra. In this parasite, they only have a small jazz quartet.
• The Structure: It has a "catalytic core" (the musicians playing the notes) and a "TcTINTIN" module (the conductor).
• The Twist: Even though it's smaller, it looks very similar to ancient versions of these complexes found in early life forms. This suggests that the basic design of this "gene-editing machine" is very old and hasn't changed much over billions of years.

2. The CRKT Team: The Symmetrical Fortress

The CRKT team is a massive, complex machine.

• The Structure: The scientists found that the core of this team is built with central symmetry.
• The Analogy: Imagine a medieval castle with a central tower. If you draw a line through the middle, the left side is a perfect mirror image of the right side.
• The Components: It has two copies of every major part (like having two engines, two wheels, etc.). This symmetry makes the machine incredibly stable and efficient.
• The "BET" Module: There's a smaller sub-group (BDF1 and BDF4) that acts like a detachable trailer. It connects to the main castle but can also hang out separately in the cytoplasm, potentially linking the cell's energy metabolism (glycosomes) with its genetic control.

Why Does This Matter? (The "Aha!" Moment)

The scientists didn't just draw pretty pictures; they found weak spots.

1. The Glue Points: They identified exactly where the proteins touch each other. For example, they found that a specific part of one protein (BDF6) acts like a bridge connecting two different modules. If you break that bridge, the whole machine falls apart.
2. New Drug Targets: Current drugs try to jam the "magnetic hook" itself. But this paper suggests we could design drugs that jam the bridges between the proteins instead. This is like trying to stop a car not by clogging the engine, but by removing the axles.
3. Specificity: Because these bridge structures are unique to the parasite and different from humans, a drug targeting them would kill the burglar without hurting the patient.

Summary

This paper is like a detective story where scientists:

1. Used glue to find out who the parasite's proteins are friends with.
2. Used AI to build a 3D model of their secret headquarters.
3. Discovered that the headquarters is built with mirror-image symmetry and has a smaller, ancient design than human versions.
4. Found the exact screws and bolts holding the machine together, offering a new blueprint for designing better medicines to cure Chagas disease.

Technical Summary

1. Problem Statement

Trypanosoma cruzi, the causative agent of Chagas disease, lacks effective treatments for its chronic stage, with current drugs showing limited efficacy and high toxicity. Bromodomain factors (BDFs) are epigenetic readers that recognize acetylated lysines and regulate gene expression, making them promising therapeutic targets. However, the structural organization, stoichiometry, and specific composition of BDF-containing complexes in trypanosomatids remain poorly understood. Previous studies in related organisms (T. brucei, Leishmania) suggested the existence of complexes like CRKT and NuA4, but significant differences in subcellular localization (e.g., extranuclear BDF1/BDF3 in T. cruzi vs. nuclear in others) and a lack of high-resolution structural data hindered rational drug design.

2. Methodology

The authors employed a hybrid "wet-lab" and "dry-lab" approach to reconstruct interactomes and infer 3D structures:

A. Experimental Approach (Proximity Labeling):

• System: Stable T. cruzi epimastigote cell lines (Dm28c strain) were generated expressing N-terminal 3xHA-TurboID fusions for five BDFs (BDF2, BDF3, BDF4, BDF5, BDF6, BDF8).
• Controls: Two spatial controls were used to distinguish specific interactions from background noise:
  • Cytoplasmic: TurboID-GFP.
  • Nuclear: TurboID-GFP-NLS (Nuclear Localization Signal).
• Optimization: Tetracycline-inducible expression was optimized to minimize overexpression artifacts while ensuring sufficient biotinylation. Biotin supplementation was deemed unnecessary due to serum content.
• Purification & MS: Proteins were biotinylated in vivo for 24 hours, purified using streptavidin beads, and analyzed via Label-Free Quantification (LFQ) Mass Spectrometry.
• Validation: Indirect immunofluorescence (IFI) confirmed subcellular localizations. Yeast Two-Hybrid (Y2H) assays validated specific domain interactions (e.g., BDF1-BDF4).

B. Computational Approach (Structure Prediction & Stoichiometry):

• Tool: The authors utilized MultimerMapper, a custom pipeline developed in their lab, combined with AlphaFold3 (AF3).
• Strategy:
  1. Stoichiometric Space Exploration: The algorithm iteratively predicts dimeric, trimeric, and higher-order oligomers to find "convergent stoichiometries" (stable complexes where no further subunits can be added without destabilization).
  2. PPI Frequency Analysis: Interactions observed frequently across different modeling contexts were prioritized as high-confidence.
  3. Combinatorial Assembly: For large complexes exceeding AF3 token limits (CRKT core), CombFold was used to assemble pre-predicted subunits.
  4. Domain Identification: Foldseek was used to identify structural homologs for hypothetical proteins.
• Validation: The authors correlated the spatial distances between protein centers of mass in the predicted models with their enrichment levels in proximity labeling experiments, finding a significant negative correlation (Spearman $\rho = -0.623$), validating the structural models.

3. Key Results

A. Subcellular Localization and Proteome Definition:

• BDF2, BDF5, BDF6, BDF7: Confirmed as highly nuclear.
• BDF1, BDF3: Confirmed as predominantly extranuclear (cytoplasmic/peroxisomal/glycosomal), consistent with previous reports but contrasting with T. brucei orthologs.
• BDF4, BDF8: Showed mixed nucleocytoplasmic localization.
• A high-confidence nuclear proximity proteome was defined, filtering out cytoplasmic noise.

B. Identification of Two Major Complexes:
The proximity networks revealed two distinct, highly interconnected complexes:

1. CRKT Complex (Conserved Regulators of Kinetoplastid Transcription):

   • Components: BDF3, BDF4, BDF5, BDF8, HAT2, ENT, BDF5BP, PARPL (a PARP-like protein), and hypothetical proteins EPL2 and EPL2ap.
   • Structure: Organized into three modules:
     • Core Module: A symmetric heterotetramer (2:2 stoichiometry) of ENT and BDF5BP, binding two copies each of BDF5, BDF8, and PARPL. This module exhibits central symmetry.
     • Catalytic Module: Composed of HAT2, EPL2, and EPL2ap (1:1:1 stoichiometry). EPL2 bridges HAT2 and EPL2ap.
     • BET Module: Composed of BDF1 and BDF4. BDF1 interacts with BDF4 via the $\alpha$N domain of BDF1 and the TINB1 domain of BDF4.
   • Novelty: The core module has a unique 2:2:2:2:2:2 stoichiometry with central symmetry. BDF1 and BDF3 (extranuclear) are integral to this network, suggesting a link between cytoplasmic processes and nuclear regulation.

2. NuA4 Complex:

   • Components: BDF6, HAT1, EAF6, Yaf9/YEA2, EPL1, MRGx, MRGBP, INGL (ING-like), and DNTL (DMAP1 N-terminal-like).
   • Structure: Organized into two modules:
     • TcTINTIN Module: BDF6, MRGx, and MRGBP.
     • Catalytic Module: Resembles the yeast piccolo-NuA4 (lacking the TRA module). It contains HAT1 anchored to a scaffold of INGL, EAF6, and EPL1.
   • Linkage: The TcTINTIN module connects to the catalytic module via the C-terminal domain (CTD) of BDF6 interacting with EPL1 and Yaf9.

C. Structural Insights and Novel Domains:

• TINB Domains: The C-terminal domains of BDF4 (TINB1) and ENT (TINB3) were identified as specific interactors for the $\alpha$N domains of BDF1 and BDF3, respectively.
• PARPL: A novel PARP-like protein (10g308) lacking the catalytic WGR domain but retaining an HD domain, suggesting a unique regulatory role.
• ET Domain Recognition: The ET domain of BDF3 was predicted to recognize linear motifs ([LV][TR]L) in BDF4, BDF5, and EPL2ap, facilitating dynamic recruitment.

4. Significance and Implications

• Structural Framework for Drug Design: This study provides the first high-resolution structural models of T. cruzi epigenetic complexes. It moves beyond simple "bromodomain pocket" inhibition to propose targeting specific protein-protein interfaces (PPIs) essential for complex assembly (e.g., BDF5-BDF5BP, BDF6-EPL1).
• Evolutionary Insight: The T. cruzi NuA4 complex resembles the yeast piccolo-NuA4 rather than the full mammalian complex, reflecting the polycistronic transcription mechanism of trypanosomatids. The presence of TINTIN-like modules in early-diverging eukaryotes (Discoba) suggests an ancient evolutionary origin for these epigenetic regulators.
• Mechanism of Compartmentalization: The findings resolve the paradox of extranuclear BDFs (BDF1/BDF3) being part of nuclear complexes. The authors propose a "shuttling" mechanism where BDF4 recruits BDF1 to the nucleus by masking its peroxisomal signal (PTS-2), linking metabolic state to epigenetic regulation.
• Methodological Advancement: The study demonstrates the power of combining proximity labeling with systematic stoichiometric space exploration (MultimerMapper) to resolve complex, dynamic interactomes that are difficult to capture via traditional co-immunoprecipitation or static structural biology.

In conclusion, the paper maps the structural and stoichiometric landscape of T. cruzi epigenetic machinery, identifying critical interfaces that could be targeted to disrupt parasite viability and offering a blueprint for rational drug design against Chagas disease.